Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1 n-3 DPA .

Authors :: Nesman JI
Gangestad Primdahl K
Tungen JE
Palmas F
Dalli J
Hansen TV
Source :: Molecules (Basel, Switzerland) [Molecules] 2019 Sep 05; Vol. 24 (18). Date of Electronic Publication: 2019 Sep 05.
Publication Year :: 2019
Abstract: PD1 <subscript>n-3 DPA</subscript> belongs to the protectin family of specialized pro-resolving lipid mediators. The protectins are endogenously formed mediators that display potent anti-inflammatory properties and pro-resolving bioactivities and have attracted interest in drug discovery. However, few studies have been reported of the secondary metabolism of the protectins. To investigate the metabolic formation of the putative C22 mono-hydroxylated product, coined 22-OH-PD1 <subscript>n-3 DPA</subscript> , a stereoselective synthesis was performed. LC/MS-MS data of synthetic 22-OH-PD1 <subscript>n-3 DPA</subscript> matched the data for the biosynthetic formed product. Cellular studies revealed that 22-OH-PD1 <subscript>n-3 DPA</subscript> is formed from n-3 docosapentaenoic acid in human serum, and we confirmed that 22-OH-PD1 <subscript>n-3 DPA</subscript> is a secondary metabolite produced by ω-oxidation of PD1 <subscript>n-3 DPA</subscript> in human neutrophils and in human monocytes. The results reported are of interest for enabling future structure-activity relationship studies and provide useful molecular insight of the metabolism of the protectin class of specialized pro-resolving mediators.